TKTL1 and Familial prostate cancer: Whereas the sensitivity and specificity of EDIM-Apo10 (92.0 and 94.6, respectively) and EDIM-TKTL1 (90.6 and 95.9, respectively) was very good, the combined score of EDIM-Apo10 and EDIM-TKTL1 was superior, leading to the extraordinary sensitivity of 95.8% and specificity of 97.3%, with the breast, oral cavity, and prostate cancers being detected [2] (Figure 3).